IRIS
ALTIERI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.287
NA - Nord America 1.835
SA - Sud America 526
EU - Europa 459
AF - Africa 157
Continente sconosciuto - Info sul continente non disponibili 119
OC - Oceania 2
Totale 5.385
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.741
SG - Singapore 973
VN - Vietnam 402
BR - Brasile 380
HK - Hong Kong 345
CN - Cina 204
IT - Italia 162
BD - Bangladesh 159
ZA - Sudafrica 115
NL - Olanda 101
FR - Francia 93
AR - Argentina 61
IN - India 43
CA - Canada 40
GB - Regno Unito 27
MX - Messico 27
IQ - Iraq 23
CO - Colombia 18
EC - Ecuador 18
JP - Giappone 16
TR - Turchia 14
DE - Germania 13
ID - Indonesia 13
MY - Malesia 13
MA - Marocco 12
VE - Venezuela 12
RU - Federazione Russa 11
PE - Perù 10
PK - Pakistan 10
PY - Paraguay 9
UA - Ucraina 9
CL - Cile 8
PL - Polonia 8
SA - Arabia Saudita 8
TH - Thailandia 8
EG - Egitto 7
ES - Italia 7
PH - Filippine 7
AZ - Azerbaigian 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
JM - Giamaica 5
KE - Kenya 5
UY - Uruguay 5
EE - Estonia 4
KG - Kirghizistan 4
NI - Nicaragua 4
RS - Serbia 4
SE - Svezia 4
TN - Tunisia 4
TW - Taiwan 4
AL - Albania 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GT - Guatemala 3
AU - Australia 2
BZ - Belize 2
HN - Honduras 2
IE - Irlanda 2
IR - Iran 2
JO - Giordania 2
KR - Corea 2
MD - Moldavia 2
MM - Myanmar 2
MN - Mongolia 2
MU - Mauritius 2
NP - Nepal 2
PA - Panama 2
QA - Qatar 2
SC - Seychelles 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BM - Bermuda 1
CG - Congo 1
CR - Costa Rica 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
ML - Mali 1
MR - Mauritania 1
NG - Nigeria 1
PS - Palestinian Territory 1
RO - Romania 1
SN - Senegal 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
VG - Isole Vergini Britanniche 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 5.267
Salva come PNG Salva come JPEG
Città #
San Jose 544
Singapore 360
Hong Kong 331
Council Bluffs 233
Ashburn 203
Ho Chi Minh City 139
Johannesburg 107
Lauterbourg 87
Hanoi 79
Boardman 54
Dallas 50
Los Angeles 47
Santa Clara 44
Beijing 29
New York 29
São Paulo 29
Milan 26
Phoenix 22
Buffalo 19
Columbus 16
Parma 16
Rio de Janeiro 16
Da Nang 15
Hefei 14
Haiphong 13
Rome 13
Brooklyn 11
Montreal 11
Tokyo 11
Biên Hòa 10
Chicago 10
Des Moines 10
Mexico City 10
Brasília 9
Can Tho 8
Orem 8
Asunción 7
Baghdad 7
Belo Horizonte 7
Curitiba 7
Denver 7
Kuala Lumpur 7
San Francisco 7
Warsaw 7
Bologna 6
Casablanca 6
Chennai 6
Guayaquil 6
Lima 6
Quito 6
Salvador 6
Toronto 6
Würzburg 6
Buenos Aires 5
Dhaka 5
La Paz 5
Medellín 5
Naples 5
Shanghai 5
Tashkent 5
Thái Bình 5
Verona 5
Wuhan 5
Zhengzhou 5
Atlanta 4
Baku 4
Bishkek 4
Bogotá 4
Cairo 4
Cape Town 4
Catania 4
Changsha 4
Charlotte 4
Erbil 4
Fortaleza 4
Frankfurt am Main 4
Istanbul 4
Joinville 4
Karachi 4
London 4
Managua 4
Montevideo 4
Nairobi 4
New Delhi 4
Piracicaba 4
Queens 4
Recife 4
Santiago 4
Shijiazhuang 4
São José 4
São José dos Campos 4
Tianjin 4
Bangkok 3
Basra 3
Belgrade 3
Bắc Giang 3
Campinas 3
Canoas 3
Caracas 3
Conselheiro Lafaiete 3
Totale 2.934
Salva come PNG Salva come JPEG
Nome #
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma 114
Recovery of hypopituitarism in macroprolactinomas: a comparison of medical vs. surgical treatment. Results from a European multicenter study 103
Machine learning-based survival prediction tool for adrenocortical carcinoma 94
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas 91
Bone Metastases in Neuroendocrine Neoplasms: From Pathogenesis to Clinical Management 88
Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept 80
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? 80
Exploring sex-specific hematological changes and their impact on quality of life in patients with prolactinoma 78
Canine insulinoma as a model for human malignant insulinoma research: Novel perspectives for translational clinical studies 75
"Expression and prognostic relevance of PD-1, PD-L1 and CTLA-4 immune checkpoints in adrenocortical carcinoma" 72
4. Role of Bone Metastases in Lung Neuroendocrine Neoplasms: Clinical Presentation, Treatment and Impact on Prognosis 72
Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study 71
SOX2+ sustentacular cells are stem cells of the postnatal adrenal medulla 70
Vitamin D and pancreas: The role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer 69
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective 66
Mitotane treatment of adrenocortical carcinoma induces tumoural secretion of GDF-15: Impact on poor prognosis and impaired responsiveness to immunotherapy 66
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma 65
Bone Metabolism and Vitamin D Implication in Gastroenteropancreatic Neuroendocrine Tumors 64
An Italian Survey of compliance with major guidelines for L-thyroxine of primary hypothyroidism 64
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 63
A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in Italy 62
Single-nucleus and spatial transcriptome reveal adrenal homeostasis in normal and tumoral adrenal gland 62
Chronic low-dose glucocorticoid inhalatory therapy as a cause of bone loss in a young man: case report 62
Focus on vitamin D and the adrenal gland 61
Medical therapy of endogenous Cushing's syndrome with steroidogenesis inhibitors: treatment rationale, available drugs, and therapeutic effects 61
Calcitonin in thyroid and extra-thyroid Neuroendocrine Neoplasms: the two-faced Janus 60
Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinoma 60
Adrenal disorders: Is there Any role for vitamin D? 59
The interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma 58
Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study 57
Recovery of adrenal function after stopping mitotane in patients with adrenocortical carcinoma 57
Chronotype and cardio metabolic health in obesity: does nutrition matter? 57
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study 56
The Value of Local Therapies in Advanced Adrenocortical Carcinoma 55
Bilateral inferior petrosal sinus sampling with human CRH stimulation in ACTH-dependent Cushing's syndrome: results from a retrospective multicenter study 55
Clinical and penile Doppler outcomes using a modified, tourniquet free, Nesbit plication for severe Peyronie's disease 54
Adrenocortical tumors and insulin resistance. What is the first step? 53
Circulating microRNA Expression in Cushing's Syndrome 53
Vitamin D and pancreas: the role of sunshine vitamin in the pathogenesis of Diabetes Mellitus and Pancreatic Cancer 51
Calcium and vitamin D supplementation. Myths and realities with regard to cardiovascular risk 51
Vitamin D and chronic diseases: the current state of the art 51
Vitamin D deficiency and tumor aggressiveness in gastroenteropancreatic neuroendocrine tumors 50
High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study 50
Next-generation therapies for adrenocortical carcinoma 50
Management of Patients with Glucocorticoid-Related Diseases and COVID-19 49
Cellular landscape of adrenocortical carcinoma at single-nuclei resolution 49
Sex differences in carcinoid syndrome: A gap to be closed 49
Nutrition and neuroendocrine tumors: an update of the literature 48
The role of Insulin-like Growth Factor (IGF) system in the adrenocortical tumors 48
Recurrence-Free Survival in Early and Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung after Complete Tumor Resection 47
Low bone mineral density in a growth hormone deficient (GHD) adolescent 47
FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma 46
MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma 46
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 46
Shedding new light on female fertility: The role of vitamin D 46
Integrative genomic analysis reveals a conserved role for prolactin signalling in the regulation of adrenal function 46
Early Detection of Recurrence and Progress Using Serum Steroid Profiling by LC-MS/MS in Patients with Adrenocortical Carcinoma 45
Erythropoiesis in Cushing syndrome: sex-related and subtype-specific differences. Results from a monocentric study 45
PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma 45
Targeted molecular analysis in adrenocortical carcinomas: a strategy towards improved personalized prognostication 44
Leydig cell tumour and giant adrenal myelolipoma associated with adrenogenital syndrome: a case report with a review of the literature 44
ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas 44
Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma 43
Role of Bone Metastases in Lung Neuroendocrine Neoplasms: Clinical Presentation, Treatment and Impact on Prognosis 43
Current evidence on vitamin D deficiency and kidney transplant: What's new? 43
Does vitamin D play a role in Autoimmune Endocrine Disorders? A proof of concept 43
Performance of DNA-based biomarkers for classification of adrenocortical carcinoma: a prognostic study 42
Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical Carcinoma 42
Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors <2 cm 42
Notch1 pathway in adrenocortical carcinomas: correlation with clinical outcome 42
Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors 42
Gemcitabine-Based Chemotherapy In Adrenocortical Carcinoma: A Multicentric Study On Efficacy and Predictive Factors 42
Subtype-specific pattern of white blood cell differential in endogenous hypercortisolism 41
Outcome of Immunotherapy in Adrenocortical Carcinoma - A retrospective cohort study 41
Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study 40
Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness 40
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question 39
Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing's Syndrome: Results From a Single Center Cohort Study 38
Editorial: Endocrine malignancies: from pathophysiology to current clinical and surgical therapeutic approaches 38
Morbidity in Patients with Chronic Adrenal Insufficiency - Cardiovascular Risk Factors and Hospitalization Rate Compared to Population Based Controls 38
Vitamin D and Bone Metabolism in Adult Patients with Neurofibromatosis Type 1 38
Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma 38
Effects of germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on mitotane treatment in adrenocortical carcinoma: a multicenter ENSAT study 37
Inflammation-based scores as predictors of treatment response in advanced adrenocortical carcinoma 37
Special Issue: Present and Future of Personalised Medicine for Endocrine Cancers 36
Prognostic role of targeted methylation analysis in paraffin-embedded samples of adrenocortical carcinoma 36
Consecutive adrenal Cushing´s syndrome and Cushing´s disease in a patient with somatic CTNNB1, USP8, and NR3C1 mutations 35
Novel AIP mutation in exon 6 causing acromegaly in a German family 35
Radioligand Therapy in Patients with Lung Neuroendocrine Tumors: A Systematic Review on Efficacy and Safety 35
RNA-Sequencing and Somatic Mutation Status of Adrenocortical Tumors: Novel Pathogenetic Insights 35
EndoCompass project: research roadmap for adrenal and cardiovascular endocrinology 34
Targeted gene expression profile reveals CDK4 as therapeutic target for selected patients with adrenocortical carcinoma 34
Patient empowerment and the Mediterranean diet as a possible tool to tackle prediabetes associated with overweight or obesity: a pilot study 34
Expression of SOAT1 in adrenocortical carcinoma and response to mitotane monotherapy: an ENSAT multicenter study 33
Bone metabolism, bone mass and structural integrity profile in professional male football players 32
Current clinical management and outcome of patients with adrenal cortical carcinoma (ACC) with rare histological subtypes—an ENSAT cohort study 31
The Importance of Being a ‘Lark' in Post-Menopausal Women with Obesity: A Ploy to Prevent Type 2 Diabetes Mellitus? 31
Identifying New Potential Biomarkers in Adrenocortical Tumors Based on mRNA Expression Data Using Machine Learning 31
Current Evidence on Local Therapies in Advanced Adrenocortical Carcinoma 31
Lack of sensitivity of diagnostic Cushing-scores in Germany: a multicenter validation 31
Totale 5.147
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.770
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025875 0 0 0 0 0 0 0 0 275 206 50 344
2025/20263.622 178 439 479 262 486 149 427 90 418 277 209 208
2026/2027888 149 296 230 213 0 0 0 0 0 0 0 0
Totale 5.385